CH
IONS icon

Cromwell Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Cromwell Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7K Buy
34
+16
+89% +$1.2K ﹤0.01% 787
2026
Q1 		$1.35K Hold
18
– – ﹤0.01% 791
2025
Q4 		$1.42K Hold
18
– – ﹤0.01% 751
2025
Q3 		$1.18K Hold
18
– – ﹤0.01% 804
2025
Q2 		$711 Buy
+18
New +$589 ﹤0.01% 889

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

Cromwell Holdings's IONS Position: Q2 2026 in Review

Cromwell Holdings increased its Ionis Pharmaceuticals (IONS) stake by 89% in Q2 2026, buying an estimated $1.2K and bringing the position to 34 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Cromwell Holdings first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Cromwell Holdings held 34 shares of Ionis Pharmaceuticals worth $2.7K as of Q2 2026.
  • Cromwell Holdings bought 16 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.2K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #787 holding.
  • Cromwell Holdings first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.